Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin.
Bassi G, Guilloton F, Menard C, Di Trapani M, Deschaseaux F, Sensebé L, Schrezenmeier H, Giordano R, Bourin P, Dominici M, Tarte K, Krampera M. Bassi G, et al. Among authors: schrezenmeier h. Tissue Eng Part A. 2015 Feb;21(3-4):767-81. doi: 10.1089/ten.TEA.2014.0269. Epub 2014 Dec 11. Tissue Eng Part A. 2015. PMID: 25322665 Free PMC article.
Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration.
Veronesi E, Murgia A, Caselli A, Grisendi G, Piccinno MS, Rasini V, Giordano R, Montemurro T, Bourin P, Sensebé L, Rojewski MT, Schrezenmeier H, Layrolle P, Ginebra MP, Panaitescu CB, Gómez-Barrena E, Catani F, Paolucci P, Burns JS, Dominici M. Veronesi E, et al. Among authors: schrezenmeier h. Tissue Eng Part C Methods. 2014 Mar;20(3):239-51. doi: 10.1089/ten.TEC.2013.0250. Epub 2013 Aug 20. Tissue Eng Part C Methods. 2014. PMID: 23845029 Free PMC article.
Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.
Menard C, Pacelli L, Bassi G, Dulong J, Bifari F, Bezier I, Zanoncello J, Ricciardi M, Latour M, Bourin P, Schrezenmeier H, Sensebé L, Tarte K, Krampera M. Menard C, et al. Among authors: schrezenmeier h. Stem Cells Dev. 2013 Jun 15;22(12):1789-801. doi: 10.1089/scd.2012.0594. Epub 2013 Feb 25. Stem Cells Dev. 2013. PMID: 23339531 Free PMC article.
Effect of high-dose irradiation on human bone-marrow-derived mesenchymal stromal cells.
Fekete N, Erle A, Amann EM, Fürst D, Rojewski MT, Langonné A, Sensebé L, Schrezenmeier H, Schmidtke-Schrezenmeier G. Fekete N, et al. Among authors: schrezenmeier h. Tissue Eng Part C Methods. 2015 Feb;21(2):112-22. doi: 10.1089/ten.TEC.2013.0766. Epub 2014 Jul 22. Tissue Eng Part C Methods. 2015. PMID: 24918644 Free PMC article.
Mesenchymal stem cells for clinical application.
Sensebé L, Krampera M, Schrezenmeier H, Bourin P, Giordano R. Sensebé L, et al. Among authors: schrezenmeier h. Vox Sang. 2010 Feb;98(2):93-107. doi: 10.1111/j.1423-0410.2009.01227.x. Epub 2009 Aug 3. Vox Sang. 2010. PMID: 19663934 Review.
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial.
Gómez-Barrena E, Rosset P, Gebhard F, Hernigou P, Baldini N, Rouard H, Sensebé L, Gonzalo-Daganzo RM, Giordano R, Padilla-Eguiluz N, García-Rey E, Cordero-Ampuero J, Rubio-Suárez JC, Stanovici J, Ehrnthaller C, Huber-Lang M, Flouzat-Lachaniette CH, Chevallier N, Donati DM, Ciapetti G, Fleury S, Fernandez MN, Cabrera JR, Avendaño-Solá C, Montemurro T, Panaitescu C, Veronesi E, Rojewski MT, Lotfi R, Dominici M, Schrezenmeier H, Layrolle P. Gómez-Barrena E, et al. Among authors: schrezenmeier h. Biomaterials. 2019 Mar;196:100-108. doi: 10.1016/j.biomaterials.2018.03.033. Epub 2018 Mar 19. Biomaterials. 2019. PMID: 29598897 Free article. Clinical Trial.
Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
Rojewski MT, Lotfi R, Gjerde C, Mustafa K, Veronesi E, Ahmed AB, Wiesneth M, Körper S, Sensebé L, Layrolle P, Hellem S, Schrezenmeier H. Rojewski MT, et al. Among authors: schrezenmeier h. Cytotherapy. 2019 Apr;21(4):468-482. doi: 10.1016/j.jcyt.2019.03.001. Epub 2019 Mar 27. Cytotherapy. 2019. PMID: 30926359 Free article.
Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions.
Gómez-Barrena E, Padilla-Eguiluz N, Rosset P, Gebhard F, Hernigou P, Baldini N, Rouard H, Sensebé L, Gonzalo-Daganzo RM, Giordano R, García-Rey E, Cordero-Ampuero J, Rubio-Suárez JC, García-Simón MD, Stanovici J, Ehrnthaller C, Huber-Lang M, Flouzat-Lachaniette CH, Chevallier N, Donati DM, Spazzoli B, Ciapetti G, Fleury S, Fernandez MN, Cabrera JR, Avendaño-Solá C, Montemurro T, Panaitescu C, Veronesi E, Rojewski MT, Lotfi R, Dominici M, Schrezenmeier H, Layrolle P. Gómez-Barrena E, et al. Among authors: schrezenmeier h. Injury. 2020 Apr;51 Suppl 1:S63-S73. doi: 10.1016/j.injury.2020.02.070. Epub 2020 Feb 26. Injury. 2020. PMID: 32139130 Free article. Clinical Trial.
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components.
Fekete N, Gadelorge M, Fürst D, Maurer C, Dausend J, Fleury-Cappellesso S, Mailänder V, Lotfi R, Ignatius A, Sensebé L, Bourin P, Schrezenmeier H, Rojewski MT. Fekete N, et al. Among authors: schrezenmeier h. Cytotherapy. 2012 May;14(5):540-54. doi: 10.3109/14653249.2012.655420. Epub 2012 Feb 2. Cytotherapy. 2012. PMID: 22296115 Free PMC article.
358 results